Vollmuth, P., Brugnara, G., Hansen, M. B., Nowosielski, M., Pflüger, I., Schell, M., . . . Bendszus, M. (2020). Noninvasive characterization of tumor angiogenesis and oxygenation in bevacizumab-treated recurrent glioblastoma by using dynamic susceptibility MRI: Secondary analysis of the European Organization for Research and Treatment of Cancer 26101 trial. Radiology, 297(1), . https://doi.org/10.1148/radiol.2020200978
Chicago Style (17th ed.) CitationVollmuth, Philipp, et al. "Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial." Radiology 297, no. 1 (2020). https://doi.org/10.1148/radiol.2020200978.
MLA (9th ed.) CitationVollmuth, Philipp, et al. "Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial." Radiology, vol. 297, no. 1, 2020, https://doi.org/10.1148/radiol.2020200978.